Bethesda, MD, United States of America

Azza Idris

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Azza Idris in Antibody Research

Introduction

Azza Idris, based in Bethesda, MD, is a distinguished inventor known for her significant contributions to the field of antibody research, particularly in the fight against malaria. With a total of two patents to her name, her work has far-reaching implications for disease prevention and treatment.

Latest Patents

Azza Idris holds two notable patents that focus on developing neutralizing antibodies against the Plasmodium falciparum circumsporozoite protein. These patents describe antibodies and antigen-binding fragments that specifically bind to and neutralize the circumsporozoite protein. In addition, the patents also encompass nucleic acids encoding these antibodies, vectors, and host cells. The disclosed technologies aim to innovate methods to inhibit infections, showcasing Azza's commitment to addressing pressing health issues.

Career Highlights

Throughout her career, Azza has collaborated with esteemed organizations dedicated to health and research. She has contributed significantly while working with the United States of America, represented by the Secretary of the Department of Health and Human Services, and Sanaria Inc. Her extensive work has put her at the forefront of immunological innovations, specifically aimed at combating malaria.

Collaborations

In her research journey, Azza Idris has had the pleasure of collaborating with renowned professionals, including Robert Seder and Neville Kisalu. These partnerships have enriched her research and furthered the development of groundbreaking technologies that contribute to global health.

Conclusion

Azza Idris is not only an accomplished inventor but also a pivotal figure in the ongoing battle against malaria. Her patents on neutralizing antibodies represent a crucial step toward innovative therapeutic solutions. With her experience and dedication, Azza continues to impact the field of antibody research, inspiring future generations of innovators and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…